Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2009 1
2010 1
2011 3
2012 2
2013 2
2014 3
2015 1
2016 1
2017 2
2018 2
2019 2
2020 6
2021 4
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Biospecimen Qualification in a Clinical Biobank of Urological Diseases.
Kofanova O, Paul S, Pexaras A, Bellora C, Petersons A, Schmitt M, Baker Berjaoui M, Qaoud Y, Kenk M, Wagner H, Fleshner N, Betsou F. Kofanova O, et al. Among authors: kenk m. Biopreserv Biobank. 2023 Oct 25. doi: 10.1089/bio.2022.0190. Online ahead of print. Biopreserv Biobank. 2023. PMID: 37878356
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.
Fleshner NE, Sayyid RK, Hansen AR, Chin JLK, Fernandes R, Winquist E, van der Kwast T, Sweet J, Lajkosz K, Kenk M, Hersey K, Veloso R, Berlin D, Herrera-Caceres JO, Sridhar S, Moussa M, Finelli A, Hamilton RJ, Kulkarni GS, Zlotta AR, Joshua AM. Fleshner NE, et al. Among authors: kenk m. Clin Cancer Res. 2023 Oct 2;29(19):3867-3874. doi: 10.1158/1078-0432.CCR-23-0731. Clin Cancer Res. 2023. PMID: 37439809 Clinical Trial.
Age related differences in primary testicular lymphoma: A population based cohort study.
Berjaoui MB, Herrera-Caceres JO, Li T, Qaoud Y, Tiwari R, Ma D, Khondker A, Naidu S, Ajaj R, Lajkosz K, Kenk M, Ajib K, Chandraseka T, Goldberg H, Fleshner N. Berjaoui MB, et al. Among authors: kenk m. Urol Oncol. 2023 Mar;41(3):151.e1-151.e10. doi: 10.1016/j.urolonc.2022.10.032. Epub 2023 Jan 24. Urol Oncol. 2023. PMID: 36702705
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant Tissue.
Nguyen LT, Lo CS, Fyrsta M, Nie J, Yam JY, Yen PH, Le MX, Hersey K, Kenk M, Crumbaker M, Fleshner N, Kulkarni G, Hamilton R, Jewett M, Finelli A, Evans A, Sweet J, Ohashi PS, Joshua AM. Nguyen LT, et al. Among authors: kenk m. Prostate Cancer. 2022 Jun 16;2022:6499344. doi: 10.1155/2022/6499344. eCollection 2022. Prostate Cancer. 2022. PMID: 35754788 Free PMC article.
Variability in testosterone measurement between radioimmunoassay (RIA), chemiluminescence assay (CLIA) and liquid chromatography-tandem mass spectrometry (MS) among prostate cancer patients on androgen deprivation therapy (ADT).
Tiwari R, Lajkosz K, Berjaoui M, Qaoud Y, Kenk M, Woffendin C, Caron P, Guillemette C, Fleshner N. Tiwari R, et al. Among authors: kenk m. Urol Oncol. 2022 May;40(5):193.e15-193.e20. doi: 10.1016/j.urolonc.2022.03.011. Epub 2022 Apr 16. Urol Oncol. 2022. PMID: 35437219
36 results